{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:22:06Z","timestamp":1791303726091,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,3,24]],"date-time":"2013-03-24T00:00:00Z","timestamp":1364083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/nn.3367","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T17:31:23Z","timestamp":1363973483000},"page":"562-570","source":"Crossref","is-referenced-by-count":92,"title":["Identification of NUB1 as a suppressor of mutant Huntingtin toxicity via enhanced protein clearance"],"prefix":"10.1038","volume":"16","author":[{"given":"Boxun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Al-Ramahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frada","family":"Berenshteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Gallego-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ichcho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Lacoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"DiFiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Botas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Palacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,24]]},"reference":[{"key":"BFnn3367_CR1","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group.. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971\u2013983 (1993).","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"BFnn3367_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nrn1806","volume":"6","author":"E Cattaneo","year":"2005","unstructured":"Cattaneo, E., Zuccato, C. & Tartari, M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6, 919\u2013930 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnn3367_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006549","volume":"5","author":"DC Rubinsztein","year":"2003","unstructured":"Rubinsztein, D.C. & Carmichael, J. Huntington's disease: molecular basis of neurodegeneration. Expert Rev. Mol. Med. 5, 1\u201321 (2003).","journal-title":"Expert Rev. Mol. Med."},{"key":"BFnn3367_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F.O. Huntington's disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"BFnn3367_CR5","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles, C. et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J. Biol. Chem. 285, 8808\u20138823 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR6","doi-asserted-by":"publisher","first-page":"29594","DOI":"10.1074\/jbc.M111.261032","volume":"286","author":"Y Nagashima","year":"2011","unstructured":"Nagashima, Y., Kowa, H., Tsuji, S. & Iwata, A. FAT10 protein binds to polyglutamine proteins and modulates their solubility. J. Biol. Chem. 286, 29594\u201329600 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1126\/science.1172871","volume":"324","author":"S Subramaniam","year":"2009","unstructured":"Subramaniam, S., Sixt, K.M., Barrow, R. & Snyder, S.H. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327\u20131330 (2009).","journal-title":"Science"},{"key":"BFnn3367_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.200909067","volume":"187","author":"LM Thompson","year":"2009","unstructured":"Thompson, L.M. et al. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell Biol. 187, 1083\u20131099 (2009).","journal-title":"J. Cell Biol."},{"key":"BFnn3367_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto, A., Lucas, J.J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57\u201366 (2000).","journal-title":"Cell"},{"key":"BFnn3367_CR10","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia, M. et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc. Natl. Acad. Sci. USA 104, 17204\u201317209 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn3367_CR11","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper, S.Q. et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. USA 102, 5820\u20135825 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn3367_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron, E., Denovan-Wright, E.M., Nash, K., Lewin, A.S. & Mandel, R.J. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol. Ther. 12, 618\u2013633 (2005).","journal-title":"Mol. Ther."},{"key":"BFnn3367_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau, R.L. et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Mol. Ther. 17, 1053\u20131063 (2009).","journal-title":"Mol. Ther."},{"key":"BFnn3367_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet, V. et al. Sustained effects of nonallele-specific Huntingtin silencing. Ann. Neurol. 65, 276\u2013285 (2009).","journal-title":"Ann. Neurol."},{"key":"BFnn3367_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nbt.1608","volume":"28","author":"PO Bauer","year":"2010","unstructured":"Bauer, P.O. et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 28, 256\u2013263 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnn3367_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar, S., Ravikumar, B., Floto, R.A. & Rubinsztein, D.C. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16, 46\u201356 (2009).","journal-title":"Cell Death Differ."},{"key":"BFnn3367_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2010.04.007","volume":"38","author":"M Filimonenko","year":"2010","unstructured":"Filimonenko, M. et al. The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol. Cell 38, 265\u2013279 (2010).","journal-title":"Mol. Cell"},{"key":"BFnn3367_CR18","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana, N.R. et al. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280, 11635\u201311640 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR19","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","volume":"3","author":"LS Kaltenbach","year":"2007","unstructured":"Kaltenbach, L.S. et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82 (2007).","journal-title":"PLoS Genet."},{"key":"BFnn3367_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","volume":"75","author":"DI Shirasaki","year":"2012","unstructured":"Shirasaki, D.I. et al. Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75, 41\u201357 (2012).","journal-title":"Neuron"},{"key":"BFnn3367_CR21","doi-asserted-by":"publisher","first-page":"e7275","DOI":"10.1371\/journal.pone.0007275","volume":"4","author":"J Doumanis","year":"2009","unstructured":"Doumanis, J., Wada, K., Kino, Y., Moore, A.W. & Nukina, N. RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS ONE 4, e7275 (2009).","journal-title":"PLoS ONE"},{"key":"BFnn3367_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1534\/genetics.109.112516","volume":"184","author":"S Zhang","year":"2010","unstructured":"Zhang, S., Binari, R., Zhou, R. & Perrimon, N. A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184, 1165\u20131179 (2010).","journal-title":"Genetics"},{"key":"BFnn3367_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","volume":"67","author":"JP Miller","year":"2010","unstructured":"Miller, J.P. et al. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 67, 199\u2013212 (2010).","journal-title":"Neuron"},{"key":"BFnn3367_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4161\/auto.5.5.8704","volume":"5","author":"PO Bauer","year":"2009","unstructured":"Bauer, P.O. & Nukina, N. Enhanced degradation of mutant huntingtin by rho kinase inhibition is mediated through activation of proteasome and macroautophagy. Autophagy 5, 747\u2013748 (2009).","journal-title":"Autophagy"},{"key":"BFnn3367_CR25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","volume":"118","author":"AH Brand","year":"1993","unstructured":"Brand, A.H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401\u2013415 (1993).","journal-title":"Development"},{"key":"BFnn3367_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2353\/ajpath.2006.051067","volume":"169","author":"K Tanji","year":"2006","unstructured":"Tanji, K. et al. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am. J. Pathol. 169, 553\u2013565 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnn3367_CR27","doi-asserted-by":"publisher","first-page":"20603","DOI":"10.1074\/jbc.M100920200","volume":"276","author":"K Kito","year":"2001","unstructured":"Kito, K., Yeh, E.T. & Kamitani, T. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression. J. Biol. Chem. 276, 20603\u201320609 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.chembiol.2011.12.020","volume":"19","author":"B Baldo","year":"2012","unstructured":"Baldo, B. et al. TR-FRET-based duplex immunoassay reveals an inverse correlation of soluble and aggregated mutant huntingtin in Huntington's disease. Chem. Biol. 19, 264\u2013275 (2012).","journal-title":"Chem. Biol."},{"key":"BFnn3367_CR29","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst, C.A. et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522\u20132534 (1999).","journal-title":"J. Neurosci."},{"key":"BFnn3367_CR30","doi-asserted-by":"crossref","unstructured":"Lu, B. & Palacino, J. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J . doi:10.1096\/fj.12-219220 (16 January 2013).","DOI":"10.1096\/fj.12-219220"},{"key":"BFnn3367_CR31","doi-asserted-by":"crossref","unstructured":"The HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11, 264\u2013278 (2012).","DOI":"10.1016\/j.stem.2012.04.027"},{"key":"BFnn3367_CR32","doi-asserted-by":"publisher","first-page":"46655","DOI":"10.1074\/jbc.M108636200","volume":"276","author":"T Kamitani","year":"2001","unstructured":"Kamitani, T., Kito, K., Fukuda-Kamitani, T. & Yeh, E.T. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J. Biol. Chem. 276, 46655\u201346660 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR33","doi-asserted-by":"publisher","first-page":"32905","DOI":"10.1074\/jbc.M212057200","volume":"278","author":"T Tanaka","year":"2003","unstructured":"Tanaka, T., Kawashima, H., Yeh, E.T. & Kamitani, T. Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L. J. Biol. Chem. 278, 32905\u201332913 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR34","doi-asserted-by":"publisher","first-page":"16503","DOI":"10.1074\/jbc.M310114200","volume":"279","author":"MS Hipp","year":"2004","unstructured":"Hipp, M.S., Raasi, S., Groettrup, M. & Schmidtke, G. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation. J. Biol. Chem. 279, 16503\u201316510 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR35","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nature07884","volume":"458","author":"TA Soucy","year":"2009","unstructured":"Soucy, T.A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732\u2013736 (2009).","journal-title":"Nature"},{"key":"BFnn3367_CR36","doi-asserted-by":"publisher","first-page":"17032","DOI":"10.1074\/jbc.M701153200","volume":"282","author":"EH Chew","year":"2007","unstructured":"Chew, E.H. & Hagen, T. Substrate-mediated regulation of cullin neddylation. J. Biol. Chem. 282, 17032\u201317040 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR37","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1212\/WNL.43.4.662","volume":"43","author":"DW Paty","year":"1993","unstructured":"Paty, D.W., Li, D.K. & the UBC MS\/MRI Study Group & the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43, 662\u2013667 (1993).","journal-title":"Neurology"},{"key":"BFnn3367_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1101\/SQB.1996.061.01.063","volume":"61","author":"ME MacDonald","year":"1996","unstructured":"MacDonald, M.E. et al. Targeted inactivation of the mouse Huntington's disease gene homolog Hdh. Cold Spring Harb. Symp. Quant. Biol. 61, 627\u2013638 (1996).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BFnn3367_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao, M.P. et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 269, 407\u2013410 (1995).","journal-title":"Science"},{"key":"BFnn3367_CR40","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awr333","volume":"135","author":"R Grondin","year":"2012","unstructured":"Grondin, R. et al. Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum. Brain 135, 1197\u20131209 (2012).","journal-title":"Brain"},{"key":"BFnn3367_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00401-007-0238-1","volume":"114","author":"K Tanji","year":"2007","unstructured":"Tanji, K. et al. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol. 114, 365\u2013371 (2007).","journal-title":"Acta Neuropathol."},{"key":"BFnn3367_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1326-4-11","volume":"4","author":"A Weiss","year":"2009","unstructured":"Weiss, A., Roscic, A. & Paganetti, P. Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction. Mol. Neurodegener. 4, 11 (2009).","journal-title":"Mol. Neurodegener."},{"key":"BFnn3367_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.stem.2009.07.011","volume":"5","author":"A Lacoste","year":"2009","unstructured":"Lacoste, A., Berenshteyn, F. & Brivanlou, A.H. An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell 5, 332\u2013342 (2009).","journal-title":"Cell Stem Cell"},{"key":"BFnn3367_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S.M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275\u2013280 (2009).","journal-title":"Nat. Biotechnol."},{"key":"BFnn3367_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","volume":"56","author":"J Ko","year":"2001","unstructured":"Ko, J., Ou, S. & Patterson, P.H. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res. Bull. 56, 319\u2013329 (2001).","journal-title":"Brain Res. Bull."},{"key":"BFnn3367_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss, A. et al. Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease. Anal. Biochem. 395, 8\u201315 (2009).","journal-title":"Anal. Biochem."},{"key":"BFnn3367_CR47","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss, A. et al. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. J. Clin. Invest. 122, 3731\u20133736 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnn3367_CR48","doi-asserted-by":"publisher","first-page":"26714","DOI":"10.1074\/jbc.M601603200","volume":"281","author":"I Al-Ramahi","year":"2006","unstructured":"Al-Ramahi, I. et al. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J. Biol. Chem. 281, 26714\u201326724 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnn3367_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled, L.B., Sison, J.D., Dragatsis, I., Zeitlin, S. & Chesselet, M.F. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. J. Comp. Neurol. 465, 11\u201326 (2003).","journal-title":"J. Comp. Neurol."},{"key":"BFnn3367_CR50","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/jnr.22184","volume":"88","author":"A Valencia","year":"2010","unstructured":"Valencia, A. et al. Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease. J. Neurosci. Res. 88, 179\u2013190 (2010).","journal-title":"J. Neurosci. Res."},{"key":"BFnn3367_CR51","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1172\/JCI36849","volume":"120","author":"CW Liew","year":"2010","unstructured":"Liew, C.W. et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J. Clin. Invest. 120, 2876\u20132888 (2010).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn.3367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.3367","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.3367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:13:31Z","timestamp":1684455211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn.3367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,24]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFnn3367"],"URL":"https:\/\/doi.org\/10.1038\/nn.3367","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,24]]}}}